| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 39,634 | 38,953 | 43,157 | 38,133 | | Cost of Revenue | 16,554 | 17,144 | 17,542 | 18,875 | | | Gross Profit |
-
| 21,809 | 25,614 | 19,258 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,144 | 16,056 | 12,480 | 11,560 | | Non Recurring | (3,805) | 2,784 | 1,021 | 197 | | Others | 17,588 | 12,707 | 5,689 | 16,514 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (9,738) | 6,424 | (9,013) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (4,846) | (9,738) | 6,424 | (9,013) | | Interest Expense | 4,476 | 4,417 | 4,620 | 5,317 | | Income Before Tax | (9,323) | (14,155) | 1,804 | (14,330) | | Income Tax Expense | (1,906) | (2,559) | (1,241) | (6,615) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,417) | (11,596) | 3,045 | (7,714) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,417) | (11,596) | 3,045 | (7,714) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,417) | ($11,596) | $3,045 | ($7,714) |
|
0.02% Nasdaq 
Income Statement
